AR030715A1 - Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones - Google Patents

Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones

Info

Publication number
AR030715A1
AR030715A1 ARP010104207A ARP010104207A AR030715A1 AR 030715 A1 AR030715 A1 AR 030715A1 AR P010104207 A ARP010104207 A AR P010104207A AR P010104207 A ARP010104207 A AR P010104207A AR 030715 A1 AR030715 A1 AR 030715A1
Authority
AR
Argentina
Prior art keywords
flavored
mixtures
pharmaceutical compositions
flavoring
flavoring systems
Prior art date
Application number
ARP010104207A
Other languages
English (en)
Spanish (es)
Inventor
Laman Alani
Donald Gauwitz
Dilip Kaul
John Lipari
Keenan Marsh
Richard Whelan
Vanik Petrossian
Soumojeet Ghosh
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of AR030715A1 publication Critical patent/AR030715A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
ARP010104207A 2000-09-05 2001-09-04 Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones AR030715A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65519200A 2000-09-05 2000-09-05

Publications (1)

Publication Number Publication Date
AR030715A1 true AR030715A1 (es) 2003-09-03

Family

ID=24627898

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010104207A AR030715A1 (es) 2000-09-05 2001-09-04 Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones

Country Status (10)

Country Link
EP (1) EP1315487A2 (fr)
JP (1) JP2004522698A (fr)
AR (1) AR030715A1 (fr)
AU (1) AU2001288695A1 (fr)
BR (1) BR0108433A (fr)
CA (1) CA2417258A1 (fr)
MX (1) MXPA03001952A (fr)
PE (1) PE20020373A1 (fr)
UY (1) UY26925A1 (fr)
WO (1) WO2002020057A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359945C (fr) 1999-11-12 2011-04-26 Abbott Laboratories Inhibiteurs de cristallisation dans une dispersion solide
MXPA05005335A (es) * 2002-11-22 2005-07-25 Firmenich & Cie Composiciones orales las cuales enmascaran el sabor salado de las sales.
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
GB2423711B (en) * 2005-10-24 2007-02-14 Fortune Apex Dev Ltd Method for preparing a pharmaceutical composition with enhanced mucoadhesion
JPWO2013129436A1 (ja) * 2012-02-29 2015-07-30 武田薬品工業株式会社 経口剤
US8771651B2 (en) * 2012-09-10 2014-07-08 Johnson & Johnson Consumer Companies, Inc. Mouth rinses and tooth sensitivity treatment compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111991A (en) * 1994-01-28 2000-07-26 Abbott Lab Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
AU3146997A (en) * 1996-06-03 1998-01-05 Merck & Co., Inc. Pediatric formulation for hiv protease inhibitors

Also Published As

Publication number Publication date
EP1315487A2 (fr) 2003-06-04
BR0108433A (pt) 2006-06-06
AU2001288695A1 (en) 2002-03-22
PE20020373A1 (es) 2002-05-13
CA2417258A1 (fr) 2002-03-14
WO2002020057A3 (fr) 2002-05-10
MXPA03001952A (es) 2003-09-10
JP2004522698A (ja) 2004-07-29
WO2002020057A2 (fr) 2002-03-14
UY26925A1 (es) 2002-04-26

Similar Documents

Publication Publication Date Title
CY1114631T1 (el) Φαρμακοτεχνικες μορφες εχινοκανδινης που περιεχουν επιφανειοδραστικα που σχηματιζουν μικκυλιο
BR0010984A (pt) Matrizes porosas de medicamento e processos para fabricação das mesmas
AR073793A1 (es) Formulacion farmaceutica liquida que contiene paracetamol. excipiente liquido
TR200002812T2 (tr) Efervesan formülasyonları.
ITMI20021392A1 (it) Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
PA8509001A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
WO2005020962A8 (fr) Forme galenique huileuse auto-nanoemulsifiante pour l'administration de medicaments difficilement hydrosolubles
CO5560580A2 (es) Formulaciones de sucralosa para disumular sabores desagradables
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
DK342989A (da) Betaendelseshaemmende middel
AR030715A1 (es) Sistemas saborizantes para composiciones farmaceuticas y metodos para hacer dichas composiciones
PE20030545A1 (es) Formulaciones de jarabe de ribavirina
AR023138A1 (es) Composicion para gomas de mascar medicadas, proceso de fabricacion y tabletas obtenidas con dicho proceso
Zackheim Topical 6-aminonicotinamide plus oral niacinamide therapy for psoriasis
ES2312921T3 (es) Disolucion acuosa concentrada de ambroxol.
AR006345A1 (es) Una composicion farmaceutica para administracion oral que comprende un inhibidor de proteasa del vih y un derivado de tocoferol soluble en agua, y un metodo para preparar dicha composicion.
WO2004069187A3 (fr) Formulation et administration d'un medicament a l'aide de cyclodextrines cristallines methylees
ES2310550T3 (es) Preparacion liquida acuosa de pranoprofeno.
BR0302523A (pt) Composição farmacêutica estável para administração de inibidores da hiv protease e processo de obtenção de composição farmacêutica concentrada para a administração de inibidores da hiv protease
ATE242626T1 (de) Wasserlösliche pharmazeutische darreichungsform, ausgenommen brause-formen, welche nicht- steroidale antientzündliche wirkstoffe enthält
CO4970788A1 (es) Formulaciones orales para drogas hidrofilicas
JP2007008852A (ja) プラバスタチンを含有する水性製剤の安定化方法
TH51212A (th) ระบบแต่งรสชาติสำหรับองค์ประกอบทางเภสัชกรรมและวิธีการเตรียมองค์ประกอบดังกล่าว
CA2954392A1 (fr) Pulverisation sublinguale de diclofenac
BR0202252A (pt) Composição farmacêutica solúvel estável para administração de inibidores da hiv protease e processo de obtenção de composições farmacêuticas concentradas para a administração de inibidores da hiv protease

Legal Events

Date Code Title Description
FB Suspension of granting procedure